Skip to content

An observational study on the diagnosis and disease surveillance of amyotrophic lateral sclerosis patients in China based on quantitative analysis of magnetic sensitivity imaging

An observational study on the diagnosis and disease surveillance of amyotrophic lateral sclerosis patients in China based on quantitative analysis of magnetic sensitivity imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127899
Enrollment
Unknown
Registered
2026-07-09
Start date
2026-07-09
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic lateral sclerosis

Interventions

ALS mimics group:NA
Control group:NA
ALS group:NA

Sponsors

The first affiliated hostipal of nanchang university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with ALS, MND, ALS-like syndromes, or exclusionary neurological injuries who sought treatment during the study enrollment period or whose medical records and data are available in this medical center’s medical records and database. 2. For ALS patients, the 2000 revised El Escorial diagnostic criteria must be met (clinically confirmed, highly probable, or highly probable with laboratory support). For other MND patients, they must meet the diagnostic criteria for relevant subtypes such as progressive bulbar palsy, isolated bulbar-onset ALS, flaccid-flaccid syndrome, or primary lateral sclerosis.

Exclusion criteria

Exclusion criteria: 1. Incomplete cranial MRI scans or poor image quality that prevents quantitative analysis; 2. Cases with significant cerebral small-vessel disease (high signal intensity in the subcortical white matter), cerebral hemorrhage, severe cerebral atrophy, or motion artifacts that prevent SWI quantification. Cases with comorbid neurological disorders that may interfere with cortical iron deposition (e.g., Alzheimer’s disease, severe Parkinson’s disease, etc.); 3. Incomplete clinical records (e.g., missing information on disease duration, site of onset, scale scores, or physical examination findings); 4. Patients with psychiatric disorders, severe cognitive impairment, concomitant multi-organ dysfunction, or in a critically ill condition, where data collection and assessment cannot be completed.

Design outcomes

Primary

MeasureTime frame
Clinical diagnostic evaluation;

Secondary

MeasureTime frame
Disease monitoring;

Countries

China

Contacts

Public ContactZhu Yu

The first affiliated hostipal of nanchang university

zhuyu19930703@163.com+86 791 86319508

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026